Algernon Pharmaceuticals's total assets for Q4 2025 were C$4.88M, a decrease of -0.07% from the previous quarter. TSE:AGN total liabilities were C$2.18M for the fiscal quarter, a -30.49% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.